Osteopontin promotes breast cancer recurrence by establishing an inflammatory and fibrotic tumour microenvironment mediated by pro-tumourigenic macrophages and cancer-associated fibroblasts
骨桥蛋白通过建立由促肿瘤巨噬细胞和癌症相关成纤维细胞介导的炎症和纤维化肿瘤微环境来促进乳腺癌复发
基本信息
- 批准号:475794
- 负责人:
- 金额:$ 7.65万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Studentship Programs
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-11-01 至 2025-11-01
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Breast cancer has one of the most promising prognoses yet remains the second deadliest cancer for one in eight Canadian women. Its morbidity is largely attributed to malignancies returning in patients, most of whom will eventually succumb and die from can
乳腺癌是最有希望的预后之一,但对于八分之一的加拿大女性来说,乳腺癌仍然是第二致命的癌症。其发病率在很大程度上归因于癌症患者的复发,其中大多数人最终将死于CAN。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gu Yu其他文献
Gu Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Addressing fear of cancer recurrence in parents of pediatric cancer survivors: adapting the Fear Of Recurrence Therapy (FORT) for parents and establishing acceptability and feasibility.
解决儿科癌症幸存者父母对癌症复发的恐惧:为父母调整恐惧复发疗法(FORT)并建立可接受性和可行性。
- 批准号:
488491 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Operating Grants
Targeting polyploid cells to prevent cancer recurrence
靶向多倍体细胞预防癌症复发
- 批准号:
23K18238 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
RanDx an affordable highly sensitive predictive test for breast cancer recurrence and metastasis
RanDx 是一种经济实惠的高灵敏度乳腺癌复发和转移预测测试
- 批准号:
10036244 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Collaborative R&D
Addressing fear of cancer recurrence in parents of pediatric cancer survivors: adapting the Fear Of Recurrence Therapy (FORT) for parents and establishing acceptability and feasibility.
解决儿科癌症幸存者父母对癌症复发的恐惧:为父母调整恐惧复发疗法(FORT)并建立可接受性和可行性。
- 批准号:
484366 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Operating Grants
PREPARE for Cancer Surgery Trial: multimodal PReoperative Exercise to decrease PostoperAtive disability, cancer RecurrencE and mortality in older people with frailty
准备癌症手术试验:多模式术前锻炼可减少体弱老年人的术后残疾、癌症复发和死亡率
- 批准号:
483360 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Operating Grants
Integrating Clinical, Pathologic, and Immune Features to Predict Breast Cancer Recurrence and Chemotherapy Benefit
整合临床、病理和免疫特征来预测乳腺癌复发和化疗获益
- 批准号:
10723924 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Identifying factors associated with ovarian cancer recurrence using a population-based approach
使用基于人群的方法识别与卵巢癌复发相关的因素
- 批准号:
10581186 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Combined Imaging and RNA Analyses to Predict Head and Neck Cancer Recurrence
结合成像和 RNA 分析来预测头颈癌复发
- 批准号:
10909477 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Assessing the impact of WTC dust exposure on prostate cancer recurrence
评估世贸中心粉尘暴露对前列腺癌复发的影响
- 批准号:
10749570 - 财政年份:2023
- 资助金额:
$ 7.65万 - 项目类别:
Refined Capture-Recapture Methods for Surveilling Cancer Recurrence
用于监测癌症复发的精细捕获-再捕获方法
- 批准号:
10522710 - 财政年份:2022
- 资助金额:
$ 7.65万 - 项目类别: